Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib-Reference-Cited by-同舟云学术

Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib

Published:2012-06 Issue:6 Volume:56 Page:1343-1350
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Lachenmayer Anja,Toffanin Sara,Cabellos Laia,Alsinet Clara,Hoshida Yujin,Villanueva Augusto,Minguez Beatriz,Tsai Hung-Wen,Ward Stephen C.,Thung Swan,Friedman Scott L.,Llovet Josep M.

Publisher

Elsevier BV

Subject

Hepatology

Reference41 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis;El-Serag;Gastroenterology,2007

3. Hepatocellular carcinoma;Llovet;Lancet,2003

4. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

5. Targeted therapies for hepatocellular carcinoma;Villanueva;Gastroenterology,2011

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDAC5 deacetylates c-Myc and facilitates cell cycle progression in hepatocellular carcinoma cells;Cellular Signalling;2024-12

2. A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy;ACS Pharmacology & Translational Science;2024-09-05

3. A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective Against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy;2024-03-28

4. Molecular mechanisms underlying the clinical efficacy of panobinostat involve Stochasticity of epigenetic signaling, sensitization to anticancer drugs, and induction of cellular cell death related to cellular stresses;Biomedicine & Pharmacotherapy;2023-08

5. A prognostic four-gene signature and a therapeutic strategy for hepatocellular carcinoma: Construction and analysis of a circRNA-mediated competing endogenous RNA network;Hepatobiliary & Pancreatic Diseases International;2023-06